These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2192070)

  • 1. U-shaped dose-response curves: their occurrence and implications for risk assessment.
    Davis JM; Svendsgaard DJ
    J Toxicol Environ Health; 1990 Jun; 30(2):71-83. PubMed ID: 2192070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the potential impact of benchmark dose and pharmacokinetic modeling in noncancer risk assessment.
    Clewell HJ; Gentry PR; Gearhart JM
    J Toxicol Environ Health; 1997 Dec; 52(6):475-515. PubMed ID: 9397182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response model incorporating nonlinear kinetics.
    Van Ryzin J; Rai K
    Biometrics; 1987 Mar; 43(1):95-105. PubMed ID: 3567309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response assessment strategies for endocrine-active compounds.
    Barton HA; Andersen ME
    Regul Toxicol Pharmacol; 1997 Jun; 25(3):292-305. PubMed ID: 9237331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormesis is central to toxicology, pharmacology and risk assessment.
    Calabrese EJ
    Hum Exp Toxicol; 2010 Apr; 29(4):249-61. PubMed ID: 20332169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear interpolation algorithm for low dose risk assessment of toxic substances.
    Gaylor DW; Kodell RL
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):305-12. PubMed ID: 7217854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U-shaped dose-responses in biology, toxicology, and public health.
    Calabrese EJ; Baldwin LA
    Annu Rev Public Health; 2001; 22():15-33. PubMed ID: 11274508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
    Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Can exposure to low doses have effects?].
    Apostoli P; Manno M
    G Ital Med Lav Ergon; 2003; 25(3):310-9. PubMed ID: 14582248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The U.S. Environmental Protection Agency's inhalation RfD methodology: risk assessment for air toxics.
    Jarabek AM; Menache MG; Overton JH; Dourson ML; Miller FJ
    Toxicol Ind Health; 1990 Oct; 6(5):279-301. PubMed ID: 1670284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.